# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Devic Disease

Neuromyelitis Optica
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 14 results.
Autologous Transplant To End NMO Spectrum Disorder
Status: Recruiting
Last Changed: Jul 25, 2019
First Received: Feb 04, 2019
Disease(s): Neuromyelitis Optica, Devic's Disease, NMO Spectrum Disorder
Intervention(s): Rituximab, Cyclophosphamide, Mesna, rATG, Methylprednisolone, G-CSF, IVIg, Autologous Stem Cells
Locations: Northwestern University, Feinberg School of Medicine, Chicago, Illinois, United States
Northwestern University, Chicago, Illinois, United States
Clinical Patterns of Neuromyelitis Optica Spectrum Disorders in Assiut University Hospital
Status: Recruiting
Last Changed: Jun 17, 2019
First Received: Jan 28, 2019
Disease(s): Neuromyelitis Optica Spectrum Disorder
Intervention(s): serum aquaporin 4 antibody (AQP-4-Ab), serum MOG antibody (anti-MOG), MRI brain, spine and orbit
Locations: Assiut University Hospital, Assiut, Egypt
Comparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum Disorders
Status: Not yet recruiting
Last Changed: Aug 22, 2019
First Received: Aug 22, 2019
Disease(s): Neuromyelitis Optica Spectrum Disorder
Intervention(s): blood purification equipment
A Phase III Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Neuromyelitis Optica Spectrum Disorders
Status: Recruiting
Last Changed: Jan 18, 2019
First Received: Nov 06, 2017
Disease(s): Neuromyelitis Optica Spectrum Disorders
Intervention(s): Placebo, RC18 160 mg
Locations: Beijing Hospital, Beijing, Beijing, China
The French Cohort and Biobank of Devic's Neuromyelitis Optica and Related Neurological Disorders (NMOSD) (NOMADMUS)
Status: Recruiting
Last Changed: Apr 02, 2019
First Received: Aug 01, 2016
Disease(s): Neuromyelitis Optica Spectrum Disorders, Neuromyelitis Optica Spectrum Related Disorders
Locations: Hospices Civils de Lyon / Hopital Neurologique Pierre Wertheimer, Bron, France
Pediatric NMOSD Observational Study
Status: Recruiting
Last Changed: Dec 06, 2018
First Received: Dec 06, 2018
Disease(s): Neuromyelitis Optica, NMO Spectrum Disorder
Locations: Mayo Clinic, Rochester, Minnesota, United States
Multimodel Magnetic Resonance Imaging (MRI)of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
Status: Recruiting
Last Changed: Aug 09, 2016
First Received: Jul 19, 2016
Disease(s): Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders
Intervention(s): Magnetic Resonance Imaging
Locations: Chinese PLA General Hospital, Beijing, Beijing, China
Treatment of Multiple Sclerosis and Neuromyelitis Optica With Regulatory Dendritic Cell: Clinical Trial Phase 1 B
Status: Recruiting
Last Changed: Feb 15, 2019
First Received: Nov 05, 2014
Disease(s): Multiple Sclerosis, Neuromyelitis Optica
Intervention(s): Tolerogenic Dendritic cells loaded with myelin peptides
Locations: Hospital Clinic of Barcelona, Barcelona, Spain
The French Multiple Sclerosis Registry
Status: Recruiting
Last Changed: Sep 07, 2016
First Received: Sep 07, 2016
Disease(s): Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders
Locations: Hospices Civils de Lyon / Hopital Neurologique Pierre Wertheimer, Bron, France
Optic Neuritis Differential Diagnosis Study
Status: Recruiting
Last Changed: Aug 01, 2019
First Received: Dec 13, 2017
Disease(s): Optic Neuritis, Neuromyelitis Optica, Multiple Sclerosis
Intervention(s): Neuro-ophtalmology examination
Locations: CHU of Martinique, Fort-de-France, France